{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:57Z","timestamp":1791461457853,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,22]]},"DOI":"10.7759\/cureus.67511","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T17:08:37Z","timestamp":1724346517000},"source":"Crossref","is-referenced-by-count":1,"title":["Seronegative Myasthenia Gravis: A Rare Disease Triggered by SARS-CoV-2 or a Coincidence?"],"prefix":"10.7759","author":[{"given":"Beatriz","family":"Castro Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Saianda Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Rodrigues Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent A","year":"2002","unstructured":"Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002, 2:797-804. 10.1038\/nri916","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2789","article-title":"COVID-19 and myasthenia gravis: a review of neurological implications of the SARS-COV-2","volume":"12","author":"Shah SM","year":"2022","unstructured":"Shah SM, Yasmin F, Memon RS, et al.. COVID-19 and myasthenia gravis: a review of neurological implications of the SARS-COV-2. Brain Behav. 2022, 12:e2789. 10.1002\/brb3.2789","journal-title":"Brain Behav"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab050","article-title":"High levels of neutrophil extracellular traps persist in the lower respiratory tract of critically ill patients with coronavirus disease 2019","volume":"223","author":"Ouwendijk WJ","year":"2021","unstructured":"Ouwendijk WJ, Raadsen MP, van Kampen JJ, et al.. High levels of neutrophil extracellular traps persist in the lower respiratory tract of critically ill patients with coronavirus disease 2019. J Infect Dis. 2021, 223:1512-21. 10.1093\/infdis\/jiab050","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109843","article-title":"Neutrophil extracellular trap: a key player in the pathogenesis of autoimmune diseases","volume":"116","author":"Sadeghi M","year":"2023","unstructured":"Sadeghi M, Dehnavi S, Jamialahmadi T, Johnston TP, Sahebkar A. Neutrophil extracellular trap: a key player in the pathogenesis of autoimmune diseases. Int Immunopharmacol. 2023, 116:109843. 10.1016\/j.intimp.2023.109843","journal-title":"Int Immunopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323565","article-title":"Management of patients with generalised myasthenia gravis and COVID-19: four case reports","volume":"91","author":"H\u00fcbers A","year":"2020","unstructured":"H\u00fcbers A, Lascano AM, Lalive PH. Management of patients with generalised myasthenia gravis and COVID-19: four case reports. J Neurol Neurosurg Psychiatry. 2020, 91:1124-5. 10.1136\/jnnp-2020-323565","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11472-6","article-title":"New-onset myasthenia gravis after SARS-CoV-2 infection: case report and literature review","volume":"270","author":"Tereshko Y","year":"2023","unstructured":"Tereshko Y, Gigli GL, Pez S, De Pellegrin A, Valente M. New-onset myasthenia gravis after SARS-CoV-2 infection: case report and literature review. J Neurol. 2023, 270:601-9. 10.1007\/s00415-022-11472-6","journal-title":"J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39506","article-title":"Myasthenia gravis associated with COVID-19 infection","volume":"15","author":"Sadiq W","year":"2023","unstructured":"Sadiq W, Waleed MS, Rizvi TA, Khan S, El Hage H. Myasthenia gravis associated with COVID-19 infection. Cureus. 2023, 15:e39506. 10.7759\/cureus.39506","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_33_22","article-title":"New-onset ocular myasthenia gravis following SARS-CoV-2 infection","volume":"16","author":"Banerjee P","year":"2023","unstructured":"Banerjee P, Hassan H, Alam MS. New-onset ocular myasthenia gravis following SARS-CoV-2 infection. Oman J Ophthalmol. 2023, 16:187-8. 10.4103\/ojo.ojo_33_22","journal-title":"Oman J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious onset of myasthenia gravis in a COVID-19 patient","volume":"11","author":"Huber M","year":"2020","unstructured":"Huber M, Rogozinski S, Puppe W, Framme C, H\u00f6glinger G, Hufendiek K, Wegner F. Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol. 2020, 11:576153. 10.3389\/fneur.2020.576153","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini A","year":"2021","unstructured":"Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021, 28:3537-9. 10.1111\/ene.14721","journal-title":"Eur J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo DA","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020, 173:1027-8. 10.7326\/L20-0845","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59538","article-title":"Myasthenia gravis triggered by a COVID-19 infection: a case report and literature review","volume":"16","author":"Minc\u0103 A","year":"2024","unstructured":"Minc\u0103 A, Minc\u0103 DI, Calinoiu AL, et al.. Myasthenia gravis triggered by a COVID-19 infection: a case report and literature review. Cureus. 2024, 16:e59538. 10.7759\/cureus.59538","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2022.2029683","article-title":"Ocular myasthenia gravis: a review and practical guide for clinicians","volume":"105","author":"Shuey NH","year":"2022","unstructured":"Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom. 2022, 105:205-13. 10.1080\/08164622.2022.2029683","journal-title":"Clin Exp Optom"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.04.045","article-title":"Myasthenic crisis: guidelines for prevention and treatment","volume":"261","author":"Jani-Acsadi A","year":"2007","unstructured":"Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for prevention and treatment. J Neurol Sci. 2007, 261:127-33. 10.1016\/j.jns.2007.04.045","journal-title":"J Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/188553-seronegative-myasthenia-gravis-a-rare-disease-triggered-by-sars-cov-2-or-a-coincidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T17:08:46Z","timestamp":1724346526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/188553-seronegative-myasthenia-gravis-a-rare-disease-triggered-by-sars-cov-2-or-a-coincidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.67511","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}